ROIVRoivant Sciences Ltd.Aug 6, 2026Q1 2026
Read transcript →Roivant Sciences Ltd. (ROIV) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$38.93
+6.27%
Mkt Cap $26.45B
ROIVRoivant Sciences Ltd.Aug 6, 2026ROIVRoivant Sciences Ltd.May 20, 2026Q4 2025
Read transcript →ROIVRoivant Sciences Ltd.Feb 6, 2026Q3 2025
Read transcript →ROIVRoivant Sciences Ltd.Jan 8, 2026Q2 2025
Read transcript →ROIVRoivant Sciences Ltd.Aug 11, 2025Q1 2025
Read transcript →ROIVRoivant Sciences Ltd.May 29, 2025Q4 2024
Read transcript →ROIVRoivant Sciences Ltd.Feb 10, 2025Q3 2024
Read transcript →ROIVRoivant Sciences Ltd.Nov 12, 2024Q2 2024
Read transcript →ROIVRoivant Sciences Ltd.Aug 9, 2024Q1 2024
Read transcript →ROIVRoivant Sciences Ltd.May 30, 2024Q4 2023
Read transcript →ROIVRoivant Sciences Ltd.Feb 13, 2024Q3 2023
Read transcript →ROIVRoivant Sciences Ltd.Nov 13, 2023Q2 2023
Read transcript →ROIVRoivant Sciences Ltd.Aug 14, 2023Q1 2023
Read transcript →ROIVRoivant Sciences Ltd.Jun 28, 2023Q4 2022
Read transcript →ROIVRoivant Sciences Ltd.Feb 13, 2023Q3 2022
Read transcript →ROIVRoivant Sciences Ltd.Nov 14, 2022Q2 2022
Read transcript →ROIVRoivant Sciences Ltd.Aug 15, 2022Q1 2022
Read transcript →ROIVRoivant Sciences Ltd.Jun 28, 2022Q4 2021
Read transcript →ROIVRoivant Sciences Ltd.Nov 15, 2021Q2 2021
Read transcript →